|
Volumn 17, Issue 7, 2003, Pages 1114-1116
|
HIV/AIDS prevention programs in developing countries are deficient without an appropriate scientific research infrastructure [7]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
IMMUNOGLOBULIN A;
IMMUNOGLOBULIN G;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ANTIBODY DETECTION;
COMMUNITY;
DEVELOPING COUNTRY;
DISEASE TRANSMISSION;
EPIDEMIC;
FEMALE;
FINANCIAL MANAGEMENT;
FOLLOW UP;
GOVERNMENT;
HEALTH CARE POLICY;
HEALTH PROGRAM;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE STATUS;
INFANT;
LABORATORY TEST;
LETTER;
MAJOR CLINICAL STUDY;
MEDICAL LITERATURE;
MEDICAL RESEARCH;
MEXICO;
MOTHER CHILD RELATION;
NONHUMAN;
PATIENT REFERRAL;
PERINATAL INFECTION;
POLITICS;
POLYMERASE CHAIN REACTION;
PREGNANCY;
PRENATAL CARE;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
PUBLICATION;
SEROLOGY;
SEROPREVALENCE;
VALIDATION PROCESS;
VIRUS ISOLATION;
COMMUNICABLE DISEASE CONTROL;
DISEASE TRANSMISSION, VERTICAL;
FEMALE;
HEALTH POLICY;
HIV INFECTIONS;
HUMANS;
INFANT, NEWBORN;
MEXICO;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
PRENATAL DIAGNOSIS;
|
EID: 0037879149
PISSN: 02699370
EISSN: None
Source Type: Journal
DOI: 10.1097/00002030-200305020-00034 Document Type: Letter |
Times cited : (4)
|
References (6)
|